Chemotherapy Drugs (General)

Chemotherapy Drugs (General) is a broad oncology category covering various cytotoxic agents. Because it represents multiple medicines rather than one specific drug, its properties and potential interactions may differ between agents and treatment plans.

This page provides educational reference on combining these medicines with other medicines and supplements. A clinician can help assess considerations for any individual medical condition or treatment.

Some interactions warrant particular caution because they may worsen treatment-related harm or reduce chemotherapy effects. Acetyl-L-Carnitine (ALCAR) may increase sensory peripheral neuropathy with paclitaxel or docetaxel and should not be used for neuropathy prevention during those treatments unless directed by the oncology team. Vitamin B9 (Folate) can affect toxicity risk during fluoropyrimidine therapy, especially with reduced folates and certain protocols. Vitamin B1 (Thiamine) may be depleted functionally by 5-fluorouracil and related drugs. St. John's Wort may reduce chemotherapy effects through metabolic induction. Saccharomyces Boulardii may pose an infection risk in substantially immunosuppressed or neutropenic patients, particularly when mucosal injury or a central venous catheter is present.

Several antioxidant or metabolism-related supplements, including Alpha-Lipoic Acid (ALA), Coenzyme Q10, Quercetin, Resveratrol, Vitamin C, Glutathione, Selenium, and Vitamin E, may affect chemotherapy through oxidative mechanisms or drug metabolism. For many of these combinations, the concern is theoretical, mixed, or regimen-specific rather than established across all chemotherapy. Resveratrol also has reported potential to enhance chemotherapy effects in some research, so it should not be treated as uniformly helpful or harmful. Timing and use should be reviewed with the oncology team rather than managed independently.

Some supplements are used alongside chemotherapy for supportive or adjunctive purposes. Ginger is used for chemotherapy-related nausea and vomiting; Astragalus and Turkey Tail are described as adjuncts in cancer treatment; and Green Tea Extract (EGCG) has been reported to increase doxorubicin sensitivity in drug-resistant hepatocellular carcinoma cells. These potential uses do not establish safety for every regimen. MSM has no specific established interaction, but limited treatment-period information supports oncology review before use. Consult the treating oncologist or pharmacist before combining any supplement with chemotherapy.